Work by this laboratory demonstrated that tamoxifen, the antiestrogen used to treat breast cancer, enhances TNF-α-induced expression of MnSOD by increasing the binding of the p50/p65 heterodimer of NF-κB to an enhancer in the second intron of the MnSOD gene [196]. Here, SOD2 is linked to breast carcinoma.